Literature DB >> 9652452

Disco fever: epidemic meningococcal disease in northeastern Argentina associated with disco patronage.

S T Cookson1, J L Corrales, J O Lotero, M Regueira, N Binsztein, M W Reeves, G Ajello, W R Jarvis.   

Abstract

Neisseria meningitidis is a leading cause of adult meningitis worldwide. From 5 to 14 August 1996, 8 cases of meningococcal disease occurred in Corrientes city (population 306,000) in northeastern Argentina. Those infected ranged in age from 15 to 45 years (median, 18.5). To determine risk factors for infection, a case-control study was done. Infecting isolates were serogrouped and underwent phenotyping by multilocus enzyme electrophoresis (MLEE) and pulsed-field gel electrophoresis (PFGE). Those infected were significantly more likely than those not infected to have had exposure to passive or active cigarette smoke or to have attended a particular disco. Isolates available from 6 case-patients were all serogroup C; all had identical MLEE and PFGE patterns. These data suggest that dance clubs or discos may be a focus of transmission of N. meningitidis among young people.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9652452     DOI: 10.1086/517450

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Long-term persistence of a discotheque-associated invasive Neisseria meningitidis group C strain as proven by pulsed-field gel electrophoresis and porA gene sequencing.

Authors:  K Riesbeck; P Orvelid-Mölling; H Fredlund; P Olcén
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Applying a case-crossover study design to examine transient exposures in the transmission of N. meningitidis.

Authors:  R Reintjes; H Kajueter; I Ehrhard; U van Treeck; A Ammons
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

3.  Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents.

Authors:  James H Jorgensen; Sharon A Crawford; Kristin R Fiebelkorn
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

4.  Molecular epidemiology of Neisseria meningitidis isolates from an outbreak of meningococcal disease among men who have sex with men, Chicago, Illinois, 2003.

Authors:  Susanna Schmink; John T Watson; Garry B Coulson; Roderick C Jones; Pamela S Diaz; Leonard W Mayer; Patricia P Wilkins; Nancy Messonnier; Susan I Gerber; Marc Fischer
Journal:  J Clin Microbiol       Date:  2007-08-29       Impact factor: 5.948

Review 5.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 6.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 7.  Epidemiological profile of meningococcal disease in the United States.

Authors:  Lee H Harrison
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

8.  Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C.

Authors:  T Popovic; S Schmink; N A Rosenstein; G W Ajello; M W Reeves; B Plikaytis; S B Hunter; E M Ribot; D Boxrud; M L Tondella; C Kim; C Noble; E Mothershed; J Besser; B A Perkins
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

Review 9.  Particle exposures and infections.

Authors:  A J Ghio
Journal:  Infection       Date:  2014-02-02       Impact factor: 3.553

10.  Social behavior and meningococcal carriage in British teenagers.

Authors:  Jenny MacLennan; George Kafatos; Keith Neal; Nick Andrews; J Claire Cameron; Richard Roberts; Meirion R Evans; Kathy Cann; David N Baxter; Martin C J Maiden; James M Stuart
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.